Skip to Content Skip to Search Skip to Utility Navigation Skip to Top Navigation Skip to Content Navigation
Los Alamos National Laboratory links to site home page
Optical biosensor detects protein toxins, biological pathogens1333436400000Optical biosensorDetecting viruses, bacterial infections, protein toxins and tumor specific antigens for the early diagnosis of cancer.http://farm9.staticflickr.com/8160/7639694222_132bae7d35_b.jpgPhoto of the optical biosensor and an illustration depicting details of the enhanced prototypeAlthough originally developed to address needs in environmental detection of bio threat agents, this sensor system can and is being adapted for use in medical diagnostics. In particular, current efforts include the development of this sensor system for the detection of viruses (including influenza and hantavirus), bacterial infections (e.g., tuberculosis), protein toxins (e.g., staph enterotoxin B), and tumor specific antigens for the early diagnosis of cancer (CEA, her-2-neu etc.).http://farm9.staticflickr.com/8294/7685025078_e6be75a22c_s.jpgGetting the right diagnosis fasterEarly detection of diseases and infections means people get the needed interventions quicker that puts them on the road to recovery sooner. Tech Transfer: Problem Solved!

Optical biosensor for the rapid detection of protein toxins and other biological pathogens

Applications

This sensor platform will be used for a variety of medical diagnostic issues.

  • early diagnosis of infection
  • early diagnosis of breast and other cancers
  • monitoring of signature antigens to track treatment
  • development of broad spectrum protein arrays to screen for disease (e.g., antibody arrays)
  • sensitive detection of signature antigens to track disease progression
  • environmental monitoring, bio-threat detection, food inspection and industrial uses

Benefits:

  • Ultra-high sensitivity and specificity
  • Simple use—one step with no reagents required
  • Fast detection times
  • Adapted to planar optical waveguides to facilitate miniaturization
  • Low power consumption and lightweight
  • Inexpensive, replaceable sensor elements
  • Suitable for use in a point-of-care facility

Summary

An optical biosensor has been developed for the rapid detection of protein toxins and other biological pathogens. The sensor platform is extremely flexible and has been adapted for use with virtually any recognition molecule. Accordingly, this sensor can be used to detect any signature biomolecule. Although originally developed to address needs in environmental detection of bio threat agents, this sensor system can and is being adapted for use in medical diagnostics. In particular, current efforts include the development of this sensor system for the detection of viruses (including influenza and hantavirus), bacterial infections (e.g., tuberculosis), protein toxins (e.g., staph enterotoxin B), and tumor specific antigens for the early diagnosis of cancer (CEA, her-2-neu etc.).

Development Stage: The optical biosensor has been prototyped and the protoype has been demonstrated.

Patent Status: These represent a small subset of the biosensor portfolio

  • US Patent 5,601,654  Flow Through Ion Beam Gun
  • US Patent 6,297,059 Triggered Optical Biosensor
  • US Patent 6,627,396 Influenza Biosensor
  • Nonprovisional, pending Integrated Optical Biosensor

Licensing Status: UC/LANL is seeking development and licensing partners to commercialize this technology portfolio.

/
YesContact/David Pesiri(505) 665-7279pesiri@lanl.gov

Optical biosensor detects protein toxins, biological pathogens

Detecting viruses, bacterial infections, protein toxins and tumor specific antigens for the early diagnosis of cancer.
April 3, 2012
Photo of the optical biosensor and an illustration depicting details of the enhanced prototype

Although originally developed to address needs in environmental detection of bio threat agents, this sensor system can and is being adapted for use in medical diagnostics. In particular, current efforts include the development of this sensor system for the detection of viruses (including influenza and hantavirus), bacterial infections (e.g., tuberculosis), protein toxins (e.g., staph enterotoxin B), and tumor specific antigens for the early diagnosis of cancer (CEA, her-2-neu etc.).

Contact  

Optical biosensor for the rapid detection of protein toxins and other biological pathogens

Applications

This sensor platform will be used for a variety of medical diagnostic issues.

  • early diagnosis of infection
  • early diagnosis of breast and other cancers
  • monitoring of signature antigens to track treatment
  • development of broad spectrum protein arrays to screen for disease (e.g., antibody arrays)
  • sensitive detection of signature antigens to track disease progression
  • environmental monitoring, bio-threat detection, food inspection and industrial uses

Benefits:

  • Ultra-high sensitivity and specificity
  • Simple use—one step with no reagents required
  • Fast detection times
  • Adapted to planar optical waveguides to facilitate miniaturization
  • Low power consumption and lightweight
  • Inexpensive, replaceable sensor elements
  • Suitable for use in a point-of-care facility

Summary

An optical biosensor has been developed for the rapid detection of protein toxins and other biological pathogens. The sensor platform is extremely flexible and has been adapted for use with virtually any recognition molecule. Accordingly, this sensor can be used to detect any signature biomolecule. Although originally developed to address needs in environmental detection of bio threat agents, this sensor system can and is being adapted for use in medical diagnostics. In particular, current efforts include the development of this sensor system for the detection of viruses (including influenza and hantavirus), bacterial infections (e.g., tuberculosis), protein toxins (e.g., staph enterotoxin B), and tumor specific antigens for the early diagnosis of cancer (CEA, her-2-neu etc.).

Development Stage: The optical biosensor has been prototyped and the protoype has been demonstrated.

Patent Status: These represent a small subset of the biosensor portfolio

  • US Patent 5,601,654  Flow Through Ion Beam Gun
  • US Patent 6,297,059 Triggered Optical Biosensor
  • US Patent 6,627,396 Influenza Biosensor
  • Nonprovisional, pending Integrated Optical Biosensor

Licensing Status: UC/LANL is seeking development and licensing partners to commercialize this technology portfolio.


Visit Blogger Join Us on Facebook Follow Us on Twitter See our Flickr Photos Watch Our YouTube Videos Find Us on LinkedIn